Study of WPV01 Compared With Placebo in Patients With Mild/Moderate COVID-19 Infection

Clinical trial NCT05752175 · COMPLETED

Trial details

NCT number: NCT05752175
Sponsor: Westlake Pharmaceuticals (Hangzhou) Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

COVID-19 Infection

Start date: 2023-03-10
Primary completion: 2023-05-09
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.